Effects of BNT162b2 mRNA vaccine on COVID-19 infection and hospitalisation amongst older people: matched case control study for England.

Thomas F D Mason Matt Whitston Jack Hodgson Ruth Elizabeth Watkinson Yiu-Shing Lau Omnia Abdulrazeg Matthew Sutton

Published in: BMC medicine (2021)

Receipt of the BNT162b2 mRNA vaccine is effective at reducing COVID-19 hospitalisations and infections. The nationwide vaccination of older adults in England with the BNT162b2 mRNA vaccine reduced the burden of COVID-19.

Keyphrases

coronavirus disease
sars cov
binding protein
physical activity
respiratory syndrome coronavirus
risk factors